A 62-year-old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy-related hemolytic-uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate.
hemolytic-uremic syndrome
bleomycin
hemolytic-uremic syndrome
methotrexate
hemolytic-uremic syndrome
cisplatin